Stock LYTIX LYTIX BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Lytix Biopharma

Equities

LYTIX

NO0010405780

Real-time Oslo Bors
Other stock markets
 05:13:07 2024-05-07 am EDT 		5-day change 1st Jan Change
5.58 NOK 0.00% Intraday chart for Lytix Biopharma -0.36% +14.81%
Apr. 25 Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity CI
Apr. 10 Lytix Biopharma to Raise Up to NOK55 Million via Share Offering MT

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. LYTIX Stock
  4. Revisions Lytix Biopharma
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW